Insmed Incorporated
INSM
株式のランク
#1108
Insmed Incorporated operates as a biopharmaceutical enterprise focused on... Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. The company's marketed treatment, ARIKAYCE, is administered to adult patients suffering from Mycobacterium avium complex (MAC) lung disease, serving as a component of a broader antibacterial drug regimen. In its development pipeline, Insmed is advancing Brensocatib, an oral and reversible inhibitor targeting dipeptidyl peptidase 1, which is being investigated for its potential in treating bronchiectasis and other disorders mediated by neutrophils. Additionally, the firm is developing Treprostinil Palmitil Inhalation Powder, an inhaled version of the treprostinil palmitil prodrug, designed to address pulmonary arterial hypertension and various other rare lung ailments. Founded in 1988, Insmed Incorporated maintains its primary corporate offices in Bridgewater, New Jersey.
株価
$95.88
時価総額
$20.94B
変化（1日）
0.61%
変化（1年）
-42.90%
国
US
取引 Insmed Incorporated (INSM)
カテゴリー
Healthcare
Insmed Incorporated（INSM）の発行済株式数
June 2026 時点の発行済株式数 217.35M
Insmed Incorporated の最新の財務報告および株価によると、現在の発行済株式数は 217.35M です。December 2023 の終わりには、同社は 140.43M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Insmed Incorporated（INSM）の発行済株式数の履歴（2000 ～ 2026）
各年末時点の発行済株式数
| 年 | 発行済株式数 | 変化 |
|---|---|---|
| 2026 (TTM) | 217.35M | 32.50% |
| 2024 | 164.04M | 16.81% |
| 2023 | 140.43M | 14.14% |
| 2022 | 123.04M | 9.74% |
| 2021 | 112.11M | 14.86% |
| 2020 | 97.61M | 15.43% |
| 2019 | 84.56M | 10.04% |
| 2018 | 76.84M | 15.42% |
| 2017 | 66.58M | 7.64% |
| 2016 | 61.85M | 5.72% |
| 2015 | 58.51M | 35.99% |
| 2014 | 43.02M | 22.99% |
| 2013 | 34.98M | 31.89% |
| 2012 | 26.52M | 13.59% |
| 2011 | 23.35M | 76.21% |
| 2010 | 13.25M | 4.24% |
| 2009 | 12.71M | 4.08% |
| 2008 | 12.21M | 6.49% |
| 2007 | 11.47M | 20.31% |
| 2006 | 9.53M | 95.56% |
| 2005 | 4.87M | 24.47% |
| 2004 | 3.92M | 10.00% |
| 2003 | 3.56M | 7.66% |
| 2002 | 3.31M | 0.59% |
| 2001 | 3.29M | 79.44% |
| 2000 | 1.83M | 0.00% |
類似企業や競合他社の発行済株式数
| 企業 | 発行済株式数 | 差 | 国 |
|---|---|---|---|
| 253.90M | 16.82% |
US
|
|
| 396.00M | 82.19% |
US
|
|
| 478.91M | 120.34% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -71.39% |
NL
|
